Q1 2022 13F Holders as of 3/31/2022
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
84.7M
-
Number of holders
-
106
-
Total 13F shares, excl. options
-
40.8M
-
Shares change
-
+2.14M
-
Total reported value, excl. options
-
$336M
-
Value change
-
-$10.4M
-
Number of buys
-
59
-
Number of sells
-
-53
-
Price
-
$8.22
Significant Holders of SUTRO BIOPHARMA, INC. - Common Stock, par value $0.001 per share (STRO) as of Q1 2022
131 filings reported holding STRO - SUTRO BIOPHARMA, INC. - Common Stock, par value $0.001 per share as of Q1 2022.
SUTRO BIOPHARMA, INC. - Common Stock, par value $0.001 per share (STRO) has 106 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 40.8M shares
of 84.7M outstanding shares and own 48.18% of the company stock.
Largest 10 shareholders include FRANKLIN RESOURCES INC (3.75M shares), SUVRETTA CAPITAL MANAGEMENT, LLC (3.73M shares), BlackRock Inc. (3.73M shares), BVF INC/IL (3.45M shares), EVENTIDE ASSET MANAGEMENT, LLC (2.71M shares), STATE STREET CORP (2.64M shares), VANGUARD GROUP INC (2.23M shares), BAILLIE GIFFORD & CO (1.87M shares), Holocene Advisors, LP (1.83M shares), and Frazier Life Sciences Management, L.P. (1.78M shares).
This table shows the top 106 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.